{"id":"W2809608597","doi":"10.1016/j.cgh.2018.06.023","title":"RETRACTION: Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients with Chronic HBV Infection","year":2018,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":40,"is_retracted":true,"has_abstract":false,"ca_institutions":"Toronto General Hospital; Canadian Society of Intestinal Research","funders":"Gilead Sciences","keywords":"Tenofovir alafenamide; Medicine; Bone mineral; Internal medicine; HBeAg; Bone remodeling; Gastroenterology; Tenofovir; Hepatitis B virus; FRAX; Urology; Osteoporosis; Viral load; HBsAg; Human immunodeficiency virus (HIV); Immunology; Virus; Osteoporotic fracture","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}